No Data
Tianjin Tianyao Pharmaceuticals Secures Food Production License for Amino Acids
Tianjin Tianyao Pharmaceuticals (600488.SH) has obtained the GMP certification issued by the Brazilian Health Regulatory Agency.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that the company will accept applications from October 21 to 25, 2024...
Jinyao Pharmaceutical Gets Registration Certificate for Formoterol Fumarate Inhalation Solution
Tianjin Tianyao Pharmaceuticals (600488.SH): The formoterol fumarate inhalation solution has obtained the pharmaceutical registration certificate.
On January 21, Gelonghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary Tianjin Tianyao HePing Pharmaceutical Co., Ltd. received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Formoterol Fumarate Inhalation Solution. Formoterol Fumarate Inhalation Solution is suitable for maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD), mainly for chronic bronchitis and emphysema, and can produce a lasting bronchodilator effect.
Tianjin Tianyao Pharmaceuticals (600488.SH): Signed the "Equity Custody Agreement".
On January 7, Gronghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that after approval by the company's ninth Board of Directors at the thirteenth meeting, to avoid potential competition issues with Innovent Biologics in the future, and since Innovent Biologics does not currently meet the conditions for injection into the listed company based on its Financial Indicators and Operation status, the company signed an "Equity Custody Agreement" with its affiliated party Tianyan Biotechnology, entrusting the management of the 55.5222% equity of Innovent Biologics owned by Tianyan Biotechnology, with the custody period from January 7, 2025, to January 6, 2028.
Tianjin Tianyao Pharmaceuticals Gets Listing Approval for Dexamethasone Sodium Phosphate API in Brazil
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)
